Company / Financials
MIMEDX GROUP, INC. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$418.6M
FY2025 · +20.0% YoY
Net Income
$48.6M
FY2025 · +14.5% YoY
Profit Margin
11.6%
FY2025 · net income / revenue
ROE
18.9%
FY2025 · return on equity
Total Assets
$342.7M
FY2025
Total Debt
$18.0M
0.07x debt/equity
Equity
$256.5M
FY2025
ROA
14.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$418.6M+20.0% YoYNet Income HistoryProfit after all expenses and taxes$48.6M+14.5% YoYGross Profit HistoryRevenue minus cost of goods sold$345.6M+19.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$73.0M+21.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes$63.9M+8.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$266.2M+18.3% YoYR&D Expense HistoryResearch and development spending$15.1M+22.3% YoYInterest Expense HistoryCost of borrowing and debt obligations-$6.5MIncome Tax HistoryTotal income tax expense$17.7M+15.6% YoYEPS (Basic) HistoryBasic earnings per share$0.33+13.8% YoY